The Valley Desk

NCT02562443 · Interventional trial

Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA

Overall registry status Terminated

Phase 3

Conditions MDS, Myelodysplastic Syndrome, RAEB, Refractory Anemia With Excess Blasts

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov